Los Alamitos Cardiovascular Physicians: Meet Steven T. Forman, M.D.

Steven T. Forman, MD, FACC, FSCAI, RVT

Dr. Steven Forman joined Los Alamitos Cardiovascular in 1999, and has been its managing partner since 2005. In addition to his roles at Los Alamitos Cardiovascular, Dr. Forman is director of the Performance Vein Institute of Los Alamitos—a practice focused on medical and cosmetic vein treatments.

Recognizing that each patient's needs are unique is one of the most important aspects of practicing good medicine. That understanding requires a professional commitment to engage every patient in a special, working partnership in order to ensure the finest care be given at all times...

On Medicine
Medicine is often referred to as an art, as well as a science. In order to be the best physician possible, it is not enough to be a strict scientist: One truly needs to be an artist, as well.

On Los Alamitos Cardiovascular
Our primary goal is to provide the highest quality and most comprehensive cardiovascular and endovascular care available. To meet this goal, we employ an excellent group of doctors, who are supported by a dedicated staff.

On My Specialty
Innovations in cardiovascular and endovascular medicine are at the forefront of medical technology, today. As a doctor in these fields, I am seeing both immediate, and imminent benefits to our patients. This is a very exciting time to be a physician within my chosen specialties of practice...

Dr. Steven T. Forman's Curriculum Vitae	View Printable CV

Specialty:	Cardiology, Interventional Cardiology, Endovascular Diseases, Phlebology
Board Certifications:	Certified in Phlebology American College of Phlebology 2012 Certified in Interventional Cardiology American Board of Internal Medicine 1999 (Recertification 2009) Certified in Cardiovascular Disease American Board of Internal Medicine 1997 (Recertification 2004) Certified in Internal Medicine American Board of Internal Medicine 1994 (Recertification 2004)
Additional Certifications:	GCP Certified July 2010 CITI Collaborative Institutional Training Initiative
Current Hospital Appointments:	Los Alamitos Medical Center 3751 Katella Avenue Los Alamitos, California 90720 MemorialCare Health System Long Beach Memorial Medical Center 2801 Atlantic Avenue Long Beach, California 90801 Lakewood Regional Medical Center 3700 South Street Lakewood, California 90712
Committees:	*Los Alamitos Medical Center* Chairman of Elective PCI Pilot Program June 2010 – Present Vice Chief of Staff, Medical Executive Committee January 2012 – Present Secretary/Treasurer, Medical Executive Committee January 2010 – December 2011 Chairman of Department of Medicine January 2007 – Present Chairman of Allied Health Committee January 2006 – December 2006 Member, Medical Executive Committee January 2006 – Present Member, Myocardial Infarction Quality Assurance Committee January 2001 – Present Member, Cardiovascular Quality Assurance Committee January 2000 – Present *State of California* Member, AOC (Advisory Oversight Committee) for the Elective PCI (Percutaneous Coronary Interventions) Pilot Program for the State of California June 2010 – Present
Professional Societies:	American College of Phlebology (RVT) Fellow American College of Cardiology (FACC) Fellow American College of Physicians (FACP) Fellow Society for Cardiovascular Angiography and Intervention (FSCAI) Fellow Society of Cardiovascular CT Member Los Angeles County Medical Association Member American College of Cardiology Member American Medical Association Member
Academic Appointments:	Volunteer Faculty Department of Medicine/Division of Cardiology University of California , Irvine (UCI) November 2011 – Present Instructor in Medicine Department of Medicine The New York Hospital /Cornell University Medical Center June 1996 – June 1998
Work History:	Los Alamitos Cardiovascular Los Alamitos, California 1999 – Present Cardiology Associates of North Jersey 1030 Clifton Avenue Clifton, New Jersey 07013 July 1998 – August 1999 Urgent Care Physician Memorial Sloan Kettering Cancer Center New York, New York July 1994 – June 1996
Previous Hospital Appointments:	General Hospital of Passaic 350 Boulevard Passaic, New Jersey 07055 July 1998 – August 1999 Saint Mary's Hospital 211 Pennington Avenue Passaic, New Jersey 07055 July 1998 – August 1999 Saint Joseph's Hospital and Medical Center 703 Main Street Passaic, New Jersey 07055 July 1998 – August 1999 Chilton Memorial Hospital 97 West Parkway Pomptom Plains, New Jersey 07444 July 1998 – August 1999 Passaic Beth Israel Hospital 70 Parker Avenue Passaic, New Jersey 07055 July 1998 – August 1999
Publications:	Shaknovich A, Forman ST, Parikh M, Deutsch E, Bergman G, McCaffery T, Newman GC, Tarazona N and Sanborn T. “Novel distal occluder washout methods for prevention of no-reflow during stenting of saphenous vein grafts.” Catheter Cardiovascular Intervention. 1999 Aug: 47(4): 397 – 403. Marshall ES, Raichlen JS, Forman S, Heyrich GP, Keen WD, Weitz HH. “Adenosine radionuclide perfusion imaging in the preoperative evaluation of patients undergoing peripheral vascular surgery.” American Journal of Cardiology. 1995 Oct 15: 76(11): 817 – 821.
Education:	Interventional Cardiology Fellowship The New York Hospital – Cornell University Medical Center The Division of Cardiology New York, New York July 1997 – June 1998 Cardiovascular Diseases Fellowship The New York Hospital – Cornell University Medical Center New York, New York July 1994 – June 1997 Internal Medicine Internship and Residency Thomas Jefferson University Hospital Department of Medicine Philadelphia, Pennsylvania July 1991 – June 1994 Medical Education Albany Medical College Albany, New York MD, May 1991 Undergraduate Education The Johns Hopkins University Baltimore, Maryland Bachelor of Arts in Natural Science, May 1987
Research Experience:	SILVER-AMI Risk Stratification in Older Persons with Acute Myocardial Infarction. Sub-Investigator \| 2013 – Present Sponsor: Yale University School of Medicine/NIH NCT01755052 \| http://clinicaltrials.gov/ct2/show/NCT01755052 RivaroxAFL3003: An Open Label Study Exploring two treatment strategies in patients with Atrial Fibrillation who undergo Percutaneous Coronary Intervention. Principal Investigator \| 2013 Sponsor: Janssen Scientific Affairs/Johnson & Johnson Phase III Trial to confirm the Anti-Anginal effect of T-89 in patients with Stable Angina. Principal Investigator \| 2013 Sponsor: Tasly Pharmaceuticals NCT0169580 \| http://clinicaltrials.gov/ct2/show/NCT01659580 Event Driven Trial of weekly Low-Dose Methotrexate in prevention of recurrent cardiovascular events among stable post myocardial infarction patients with Type II Diabetes or Metabolic Syndrome. Principal Investigator \| 2013 Sponsor: Center for Cardiovascular Disease Prevention Brigham and Women’s Hospital/National NCT01594333 \| http://clinicaltrials.gov/ct2/show/NCT01594333 User Comprehension Evaluation of a New Cleaning and Disinfection Procedure for the INRatio® 2PT/INR Monitoring System (ADAPT) BSTE-0159. Principal Investigator \| 2012 Sponsor: Alere San Diego Mission® PT Coagulation Monitoring System Clinical Study. Sub-Investigator \| 2012 Sponsor: ACON Laboratories, INC. The "BRIDGE" Trial (1U01HL08675501A1): Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery. Principal Investigator \| 2012 – Present Sponsor: National Institutes of Health (NIH)-National Heart, Lung and Blood Institute (NHLBI) NCT00786474 \| http://clinicaltrials.gov/ct2/show/NCT00786474 GLORIA-AF 1160.129: Global Registry on Long-Term Oral Anti-thrombotic Treatment in Patients with Atrial Fibrillation Phase II-III. Principal Investigator \| 2012 – Present Sponsor: Boehringer Ingelheim NCT01468701 \| http://clinicaltrials.gov/ct2/show/NCT01468701 California State Elective Percutaneous Coronary Intervention Pilot Program Principal Investigator \| 2010 – Present BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes. Sub-Investigator \| 2010 – 2012 Sponsor: St. Jude Medical Center NCT01062126 \| http://clinicaltrials.gov/ct2/show/NCT01062126 The PROMISE Trial: PROspective Multicenter Imaging Study for Evaluation of Chest Pain. Principal Investigator \| 2010 – Present Sponsor: National Heart, Lung, and Blood Institute (NHLBI) NCT01174550 \| http://clinicaltrials.gov/ct2/show/record/NCT01174550 ORBIT-AF I and II: Outcomes Registry for Better Informed Treatment of Atrial Fibrillation. Principal Investigator \| 2010 – Present Sponsor: Janssen Scientific Affairs, LLC Collaborator: Duke Clinical Research NCT01165710 \| http://clinicaltrials.gov/ct2/show/NCT01165710 NCT01701817 \| http://clinicaltrials.gov/ct2/show/NCT01701817 RATE: Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population. Sub-Investigator \| 2008 – 2010 Sponsor: St. Jude Medical Center NCT00837798 \| http://clinicaltrials.gov/ct2/show/NCT00837798 FREEDOM: A Frequent Optimization Study the Quick Opt ™ Method. Sub-Investigator \| 2008 – 2010 Sponsor: St. Jude Medical Center NCT00418314 \| http://clinicaltrials.gov/ct2/show/NCT00418314 ENGAGE: Phase III, randomized, double-blind, double-dummy, parallel group, multi-center, multi-national study for evaluation of efficacy and safety of DU-176b versus Warfarin in subjects with Atrial Fibrillation - Effective Anticoagulation with Xa next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48). Principal Investigator \| 2009 – Present Sponsor: Daiichi Sankyo Pharma Development NCT00781391 \| http://clinicaltrials.gov/ct2/show/record/NCT00781391 Phase III, double-blind, randomized, placebo-controlled, multi-center study evaluating the efficacy and safety of Dalcetrapib on lipids, lipoproteins, apolipoproteins and markers of CV Risk in patients hospitalized for an acute coronary syndrome (ACS) when treatment is initiated within 1 week after an ACS (Dal-ACUTE). Principal Investigator \| 2008 – 2012 Sponsor: F.Hoffmann-La Roche Ltd., Hoffmann-La Roche, Inc. , Roche Global Development. NCT01323153 \| http://clinicaltrials.gov/ct2/show/NCT01323153 Multi-center, randomized, controlled study to investigate the safety and tolerability of Intravenous Ferric Carboxymaltose (FCM) vs. Iron Dextran in treating iron deficiency anemia in subjects who are not dialysis dependent. Principal Investigator \| 2007 – 2009 Sponsor: Luitpold Pharmaceuticals, Inc. NCT00704028 \| http://clinicaltrials.gov/ct2/show/NCT0070402 Systolic and diastolic myocardial dysfunction during endotoxemia in pigs. Proctor: Roy D Goldfarb, Phd \| 1989 – 1991 Department of Physiology, Albany Medical College

Steven T. Forman, MD, FACC, FSCAI, RVT

Dr. Steven T. Forman's Curriculum Vitae

Our Physicians

News & Announcements

Subscribe to our Newsletter